Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion type Assertion NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_head.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion description "[Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_provenance.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion evidence source_evidence_literature NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_provenance.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion SIO_000772 22291012 NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_provenance.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion wasDerivedFrom befree-20140225 NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_provenance.
- NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_assertion wasGeneratedBy ECO_0000203 NP257554.RAqU_pzlGp8At8WbU10cYN0OoLrld3gCcrN-66DWpVTRw130_provenance.